Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Protein Sciences receives U.S. Department of Defense grant to develop adenovirus vaccine

Nov. 16, 2015

FDA approves label expansion for Harvoni

Nov. 13, 2015

NFKB1 identified as a biomarker for severe malarial anemia in pediatric patients

Nov. 13, 2015

Intracellular S. aureus killed using a phagolysosome-targeted antibody-antibiotic conjugate

Nov. 13, 2015

World Pneumonia Day: reducing delivery restraints and fighting antibiotic resistance

Nov. 12, 2015

XF-73 receives FDA QIDP designation

Nov. 12, 2015

Shionogi and GSK to independently develop collaboration on cephalosporin antibiotics

Nov. 12, 2015

Discovery of small-molecule bacterial riboswitch inhibitors

Nov. 12, 2015

Antimalarials targeting apicoplast optimized to derive MMV-008138

Nov. 11, 2015

Cidara Therapeutics patents bifunctional antifungal agents

Nov. 11, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...